— Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of clinical and research expertise in psychiatry, addiction, behavioral health, and pharmacology to guide Company’s development programs — –Scientific Advisory Board members are affiliated with cutting-edge programs at elite academic and medical…

Source

Previous articleRevive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Next articleBright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome